07:00 , Jul 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Cryptochrome 1 (CRY1) Cell culture studies identified a small molecule circadian rhythm regulator that could...
07:00 , Sep 23, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Diabetes Cryptochrome 1 (CRY1) Studies in mice suggest that activating CRY1 could help treat diabetes. In...